2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$5.16+$0.04 (+0.68%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.0BMarket Cap
- 14.80%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$5.16+$0.04 (+0.68%)
ABUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.12 | ||
Change | $0.00 (0.00%) | ||
Open | $5.17 | ||
High | $5.17 | ||
Low | $5.11 | ||
Previous Close | $5.12 | ||
Volume | 1,850,045 | ||
30-Day Average Volume | 4,659,393 | ||
1-Week Change | -0.58% | ||
1-Month Change | 9.64% | ||
1-Year Change | 14.80% | ||
3-Year Change | 132.73% | ||
5-Year Change | 16.89% | ||
Fundamentals | |||
Shares Outstanding | 198.1M | ||
Total Assets | $274.0M | ||
Market Cap | $1.0B | ||
Enterprise Value | $995.1M | ||
Period: QTR TTM FY | |||
Revenue | $202,000.00 | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.1M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $270.5M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -194 | ||
Enterprise Value/Revenue | 4,926 | ||
P/B | 4 | ||
P/E | -171 | ||
PEG | 2 | ||
Price/Free Cash Flow | -169 | ||
Price/Operating Cash Flow | -169 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue